Process View
The signaling process in which signal transduction is brought to an end rather than being reversibly modulated.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "termination of signal transduction"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| PRKCZ | protein kinase C, zeta | 0.740 | Human | |
| PARD6A | par-6 partitioning defective 6 homolog alpha (C. elegans) | 0.707 | ||
| CCDC115 | coiled-coil domain containing 115 | 0.467 | ||
| PARD6B | par-6 partitioning defective 6 homolog beta (C. elegans) | 0.287 | ||
| PARD6G | par-6 partitioning defective 6 homolog gamma (C. elegans) | 0.220 | ||
| NCF1 | neutrophil cytosolic factor 1 | 0.158 | ||
| ZNF71 | zinc finger protein 71 | 0.145 | ||
| SH3RF1 | SH3 domain containing ring finger 1 | 0.117 | ||
| LRRK2 | leucine-rich repeat kinase 2 | 0.104 | ||
| DUSP23 | dual specificity phosphatase 23 | 0.092 | ||
| NR1H2 | nuclear receptor subfamily 1, group H, member 2 | 0.090 | ||
| MTOR | mechanistic target of rapamycin (serine/threonine kinase) | 0.076 | ||
| NUMB | numb homolog (Drosophila) | 0.074 | ||
| CASP7 | caspase 7, apoptosis-related cysteine peptidase | 0.053 | ||
| YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide | 0.052 | ||
| NMT2 | N-myristoyltransferase 2 | 0.051 | ||
| PARD3 | par-3 partitioning defective 3 homolog (C. elegans) | 0.050 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.050 | ||
| ANXA4 | annexin A4 | 0.049 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.045 | ||
| LLGL1 | lethal giant larvae homolog 1 (Drosophila) | 0.038 | ||
| CDCP1 | CUB domain containing protein 1 | 0.037 | ||
| PICK1 | protein interacting with PRKCA 1 | 0.036 | ||
| MAPT | microtubule-associated protein tau | 0.034 | ||
| PRKCB | protein kinase C, beta | 0.027 | ||
| MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 0.025 | ||
| NCF2 | neutrophil cytosolic factor 2 | 0.021 | ||
| AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.018 | Human | |
| GABARAPL1 | GABA(A) receptor-associated protein like 1 | 0.017 | ||
| TRIM9 | tripartite motif containing 9 | 0.017 | ||
| PREX1 | phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 | 0.017 | ||
| MAP1LC3A | microtubule-associated protein 1 light chain 3 alpha | 0.017 | ||
| TSC22D1 | TSC22 domain family, member 1 | 0.016 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.016 | ||
| RHEB | Ras homolog enriched in brain | 0.016 | ||
| LCK | lymphocyte-specific protein tyrosine kinase | 0.016 | ||
| PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.015 | ||
| SH2D2A | SH2 domain containing 2A | 0.014 | ||
| DCTN1 | dynactin 1 | 0.014 | ||
| RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.014 | ||
| CDC37 | cell division cycle 37 homolog (S. cerevisiae) | 0.014 | ||
| ASXL1 | additional sex combs like 1 (Drosophila) | 0.013 | ||
| POFUT1 | protein O-fucosyltransferase 1 | 0.013 | ||
| SQSTM1 | sequestosome 1 | 0.013 | ||
| MBD1 | methyl-CpG binding domain protein 1 | 0.013 | ||
| F11R | F11 receptor | 0.013 | ||
| AKT3 | v-akt murine thymoma viral oncogene homolog 3 (protein kinase B, gamma) | 0.013 | Human | |
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.012 | ||
| PRKCA | protein kinase C, alpha | 0.012 | ||
| SPRR2A | small proline-rich protein 2A | 0.011 | ||
| MALT1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 | 0.011 | ||
| SH2D1A | SH2 domain containing 1A | 0.010 |